NCT02211729View on ClinicalTrials.gov

A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children

PHASE3CompletedINTERVENTIONAL
Enrollment

22,090

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
MalariaRespiratory Infections
Interventions
DRUG

Sulphadoxine-Pyrimethamine+ Amodiaquine+ Azithromycin

Sulphadoxine-Pyrimethamine+ Amodiaquine+ Azithromycin 4 rounds during malaria transmission season

DRUG

Sulphadoxine-pyrimethamine + amodiaquine + placebo azithromycin

Sulphadoxine-pyrimethamine + amodiaquine + placebo azithromycin 4 rounds during malaria transmission season

Trial Locations (2)

Unknown

Hounde district Hospital, Houndé

Bougouni Koulikoro District hospital, Bougouni

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02211729 - A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children | Biotech Hunter | Biotech Hunter